Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Actuate Therapeutics Inc.
National Cancer Institute (NCI)
Hoffmann-La Roche
Cellectar Biosciences, Inc.
Hoffmann-La Roche
Emory University
Eli Lilly and Company
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Seattle Children's Hospital
Seattle Children's Hospital
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Baylor College of Medicine
Bambino Gesù Hospital and Research Institute
Pfizer